Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of ...
The companies will bring together data, software and tuned models to create custom, purpose-built solutions across the drug ...
Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development.
Paris: Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and ...
The collaboration aims to integrate data, software, and tuned models to create custom solutions for the drug development process.
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm ...
, opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial ...